Insider Transactions Reported by 10 Insiders of Apogee Therapeutics, Inc.

Symbol
APGE on Nasdaq
Location
Waltham, MA

Insiders trading volume in the past year

Apogee Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michael Henderson Chief Executive Officer, Director $92.9M -$7.41M -7.39% Dec 10, 2025
Carl Dambkowski Chief Medical Officer $20.3M -$3M -12.8% Dec 4, 2025
Nimish Shah Director $15M +$15M Oct 10, 2025
Jane Henderson Chief Financial Officer $14.6M -$408K -2.71% Dec 4, 2025
Mark C. McKenna Director $997K Jun 17, 2025
Jennifer Fox Director Jun 17, 2025
Lisa Bollinger Director Jun 17, 2025
Andrew Gottesdiener Director Jun 17, 2025
William Jones Director Jun 17, 2025
Fairmount Funds Management LLC Director Jun 17, 2025

Recent Insider Transactions by Companies or Individuals for Apogee Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.